首页> 外文期刊>World Journal of Gastroenterology >Modern surgical strategies for perianal Crohn's disease
【24h】

Modern surgical strategies for perianal Crohn's disease

机译:肛周克罗恩病的现代外科策略

获取原文
           

摘要

One of the most challenging phenotypes of Crohn’s disease is perianal fistulizing disease (PFCD). It occurs in up to 50% of the patients who also have symptoms in other parts of the gastrointestinal tract, and in 5% of the cases it occurs as the first manifestation. It is associated with severe symptoms, such as pain, fecal incontinence, and a significant reduction in quality of life. The presence of perianal disease in conjunction with Crohn’s disease portends a significantly worse disease course. These patients require close monitoring to identify those at risk of worsening disease, suboptimal biological drug levels, and signs of developing neoplasm. The last 2 decades have seen significant advancements in the management of PFCD. More recently, newer biologics, cell-based therapies, and novel surgical techniques have been introduced in the hope of improved outcomes. However, in refractory cases, many patients face the decision of having a stoma made and/or a proctectomy performed. In this review, we describe modern surgical management and the most recent advances in the management of complex PFCD, which will likely impact clinical practice.
机译:克罗恩病的最具挑战性的表型之一是肛周瘘管(PFCD)。它发生在胃肠道其他地区的症状的患者中最多50%的患者,并且在5%的情况下,它作为第一个表现出来的情况。它与严重的症状有关,例如疼痛,粪便尿失禁,以及生活质量的显着降低。肛周疾病的存在结合克罗恩病的出现显着越来越糟糕的疾病课程。这些患者需要密切监测,以确定疾病恶化,次优生物药物水平和发育肿瘤的迹象的风险。过去的2年已经看到了PFCD管理的重要进步。最近,较新的生物学,基于细胞的疗法和新颖的手术技术已经引入了改进的结果。然而,在耐火性案例中,许多患者面临着患有造口造口和/或新切除术的决定。在这篇综述中,我们描述了现代外科管理以及复杂PFCD管理的最新进展,这可能会影响临床实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号